Synthesis and evaluation of hydrophilic linkers for antibody-maytansinoid conjugates

The synthesis and biological evaluation of hydrophilic heterobifunctional cross-linkers for conjugation of antibodies with highly cytotoxic agents are described. These linkers contain either a negatively charged sulfonate group or a hydrophilic, noncharged PEG group in addition to an amine-reactive N-hydroxysuccinimide (NHS) ester and sulfhydryl reactive termini. These hydrophilic linkers enable conjugation of hydrophobic organic molecule drugs, such as a maytansinoid, at a higher drug/antibody ratio (DAR) than hydrophobic SPDB and SMCC linkers used earlier without triggering aggregation or loss of affinity of the resulting conjugate. Antibody-maytansinoid conjugates (AMCs) bearing these sulfonate- or PEG-containing hydrophilic linkers were, depending on the nature of the targeted cells, equally to more cytotoxic to antigen-positive cells and equally to less cytotoxic to antigen-negative cells than conjugates made with SPDB or SMCC linkers and thus typically displayed a wider selectivity window, particularly against multidrug resistant (MDR) cancer cell lines in vitro and tumor xenograft models in vivo.

Medienart:

E-Artikel

Erscheinungsjahr:

2011

Erschienen:

2011

Enthalten in:

Zur Gesamtaufnahme - volume:54

Enthalten in:

Journal of medicinal chemistry - 54(2011), 10 vom: 26. Mai, Seite 3606-23

Sprache:

Englisch

Beteiligte Personen:

Zhao, Robert Y [VerfasserIn]
Wilhelm, Sharon D [VerfasserIn]
Audette, Charlene [VerfasserIn]
Jones, Gregory [VerfasserIn]
Leece, Barbara A [VerfasserIn]
Lazar, Alexandru C [VerfasserIn]
Goldmacher, Victor S [VerfasserIn]
Singh, Rajeeva [VerfasserIn]
Kovtun, Yelena [VerfasserIn]
Widdison, Wayne C [VerfasserIn]
Lambert, John M [VerfasserIn]
Chari, Ravi V J [VerfasserIn]

Links:

Volltext

Themen:

14083FR882
3WJQ0SDW1A
Antibodies
Immunoconjugates
Journal Article
MJE3791M4T
Maytansine
N-hydroxysuccinimide
Polyethylene Glycols
Succinimides
Sulfones

Anmerkungen:

Date Completed 01.08.2011

Date Revised 03.01.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/jm2002958

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM207702713